Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease and Its Toll Compared in Different Age Groups in Study
Differences in comorbidities, pain, healthcare utilization and psychosocial outcomes were addressed in three groups of sickle cell disease (SCD) patients, distinguished by their respective ages, in the Pain in the Sickle Cell Epidemiology Study (PiSCES). Other studies are needed to determine if age-specific healthcare measures might improve these patients’ lives.
The study, “Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project,” appeared in the journal BioMed Research International.
+myBinderRelated Content
-
CTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
-
Learning About Sickle Cell DiseaseSickle cell disease is the most common i...
-
Ask Dr. Kevin: Understanding Sickle Cell Disease"Ask Dr. Kevin” is a new feature broug...
-
Possible Cure for Sickle Cell Found in ParisHematologists, sickle cell patients, and...
-
Sickle Cell Stories: Office of Minority Health, U.S. Department of Health and Human Serviceshttps://www.youtube.com/watch?v=HFojyaji...
-
Sickle Cell Speaks: Misconceptions About the Diseasehttps://www.youtube.com/watch?v=tSEEZj9o...
-
23andMe, Morehouse School of Medicine and the Sickle Cell Foundation of Georgia Inc. launches the Sickle Cell Carrie...Atlanta, GA: April 11, 2023 — 23andMe ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.